Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute-On-Chronic Liver Failure (Phase 1)
Alzheimer Disease (Phase 1/Phase 2)
Amyotrophic Lateral Sclerosis (Phase 2)
Autoimmune Diseases (Phase 1/Phase 2)
Burkitt Lymphoma (Phase 2)
Colitis, Ulcerative (Phase 1)
COVID-19 (Phase 1)
End Stage Liver Disease (Phase 2)
Graft vs Host Disease (Phase 2)
Hematologic Neoplasms (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 1)
Hodgkin Disease (Phase 2)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 1/Phase 2)
Kidney Transplantation (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Liver Cirrhosis (Phase 1/Phase 2)
Liver Transplantation (Phase 1/Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 1)
Pemphigus (Phase 1)
Primary Myelofibrosis (Phase 1)
Respiratory Distress Syndrome (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue